Verma AM, Patel A, Subramanian S, Smith PJ, et al. From intravenous to subcutaneous infliximab in patients with inflammatory bowel disease: a pandemic-driven initiative. Lancet Gastroenterol Hepatol 2021;6:88-89.
PMID: 33444534